Press release
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflammatory Therapeutics Market: A Significant Driver Propelling The Anti-Inflammatory Therapeutics Market In 2025
Anti-Inflammatory Therapeutics Market Growth
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71 billion in 2024 to $118.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.3%. The historic growth can be attributed to factors such as the prevalence of chronic diseases, an aging population, heightened awareness, and government initiatives.
The market size for anti-inflammatory therapeutics is projected to exhibit a robust growth in the upcoming years. Going by predictions, it is set to reach $144.05 billion by 2029, fuelled by a compound annual growth rate (CAGR) of 5.0%. The expansion during the forecast period can be accredited to the emergence of innovative therapies, an upscale in healthcare spending, as well as an increased focus on rare diseases, biologics, and biosimilars. The period is also expected to witness significant trends like advances in immunotherapy, integration of artificial intelligence (AI) and machine learning (ML) in drug discovery, and broadening of indications.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861
What Are the Major Segments in the Anti-Inflammatory Therapeutics Market?
The anti-inflammatory therapeutics market covered in this report is segmented -
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, ket*oprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
What Are The Driving Anti-Inflammatory Therapeutics Market Evolution?
The increase in cases of inflammatory bowel disease is anticipated to significantly fuel the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a persisting ailment that causes inflammation in the digestive tract. Anti-inflammatory therapeutics are essential in the treatment of Crohn's disease as they alleviate inflammation, manage disease symptoms, and lower surgical risks. For example, as reported by Oxford University Press (OUP), the university's publishing department, in July 2023, the incidence rate of IBD stands at 10.9 per 100,000 person-years and its prevalence is 721 per 100,000 individuals. Hence, the escalating occurrence of inflammatory bowel disease is a key driver for the anti-inflammatory therapeutics market's growth.
Which Firms Dominate The Anti-Inflammatory Therapeutics Market Segments?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
What Trends Are Expected to Dominate the Anti-Inflammatory Therapeutics Market in the Next 5 Years?
Prominent businesses in the anti-inflammatory therapeutics sector are unveiling groundbreaking drugs to solidify their standing in the market. For example, in February 2023, US-based biotechnology firm Regeneron Pharmaceuticals Inc., and Sanofi, a pharmaceutical and healthcare company from France, introduced Kevzara (sarilumab). This product is the first and only anti-inflammatory biologic recommended for adult patients suffering from polymyalgia rheumatic (PMR), an inflammatory rheumatic condition. It is prescribed to those who don't show adequate response to corticosteroids or cannot tolerate corticosteroid tapering.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
Which Is The Largest Region In The Anti-Inflammatory Therapeutics Market?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anti-Inflammatory Therapeutics Market?
2. What is the CAGR expected in the Anti-Inflammatory Therapeutics Market?
3. What Are the Key Innovations Transforming the Anti-Inflammatory Therapeutics Industry?
4. Which Region Is Leading the Anti-Inflammatory Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflammatory Therapeutics Market: A Significant Driver Propelling The Anti-Inflammatory Therapeutics Market In 2025 here
News-ID: 4018131 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Nucleic Acid Extraction Instruments And Reagents Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nucleic Acid Extraction Instruments And Reagents Market Size Growth Forecast: What to Expect by 2025?
The market for nucleic acid extraction instruments and reagents has experienced a robust growth in the recent past. The market value is projected to rise from $4.56 billion in 2024 to $4.97 billion in…
Mobile ECG Devices Market Set To Soar Due To Escalating Incidence Of Heart-Relat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Mobile ECG Devices Industry Market Size Be by 2025?
In the past few years, the market size for mobile ECG devices has seen significant expansion. The growth rate is expected to rise from $115.35 billion in 2024 to $121.39 billion in 2025, indicating a compound annual…
Steady Expansion Forecast for Liver Cancer Diagnostics Market, Projected to Reac …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liver Cancer Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for liver cancer diagnostics has seen significant expansion in the past few years. The market, which was valued at $9.69 billion in 2024, is expected to rise to $10.32 billion in…
Emerging Laser Atherectomy Devices Market Trends: Product Innovations In The Las …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Laser Atherectomy Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been significant growth in the market size for laser atherectomy devices. The market is projected to expand from $1.22 billion in 2024 to $1.3 billion in 2025, reflecting a compound annual growth…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).
Key Highlights
- US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline…
